Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schopohl

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 19, 2008
Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance testJ Roemmler, B Otto, B Steffin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 25, 2014
Lethal generalized calcinosis and hypercalcemic crisis in primary hyperparathyroidismA Pallauf, J Schopohl, M Makeschin, et al.
Critical Care Medicine|October 3, 1999
Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcomeM W Angstwurm, J Schottdorf, J Schopohl, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1986
[Experiences with catheter jejunostomy]J Schopohl, C E Zöckler, M Brandl, et al.
Deutsche Medizinische Wochenschrift (1946)|July 4, 1997
[Diagnostic criteria for the indication of growth hormone substitution in adults. The Hypophysis and Hypophyseal Tumor Working Group of the German Society for Endocrinology]C J Strasburger, J Schopohl, P Kann, et al.
European Journal of Endocrinology|August 12, 2010
Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patientsJ Roemmler, B Otto, A M Arafat, et al.
European Journal of Endocrinology|February 22, 2001
Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegalyB Gutt, C Hatzack, K Morrison, et al.
Klinische Wochenschrift|December 3, 1984
Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF1-44, GRF1-40, GRF1-29) in normal subjectsM Losa, J Schopohl, O A Müller, et al.
Clinical Endocrinology|June 21, 2011
Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiencyJ Roemmler, A Gockel, B Otto, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 26, 2008
The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatmentJ Roemmler, B Steffin, B Gutt, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 19, 2008
Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance testJ Roemmler, B Otto, B Steffin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 25, 2014
Lethal generalized calcinosis and hypercalcemic crisis in primary hyperparathyroidismA Pallauf, J Schopohl, M Makeschin, et al.
Critical Care Medicine|October 3, 1999
Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcomeM W Angstwurm, J Schottdorf, J Schopohl, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1986
[Experiences with catheter jejunostomy]J Schopohl, C E Zöckler, M Brandl, et al.
Deutsche Medizinische Wochenschrift (1946)|July 4, 1997
[Diagnostic criteria for the indication of growth hormone substitution in adults. The Hypophysis and Hypophyseal Tumor Working Group of the German Society for Endocrinology]C J Strasburger, J Schopohl, P Kann, et al.
European Journal of Endocrinology|August 12, 2010
Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patientsJ Roemmler, B Otto, A M Arafat, et al.
European Journal of Endocrinology|February 22, 2001
Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegalyB Gutt, C Hatzack, K Morrison, et al.
Klinische Wochenschrift|December 3, 1984
Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF1-44, GRF1-40, GRF1-29) in normal subjectsM Losa, J Schopohl, O A Müller, et al.
Clinical Endocrinology|June 21, 2011
Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiencyJ Roemmler, A Gockel, B Otto, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 26, 2008
The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatmentJ Roemmler, B Steffin, B Gutt, et al.
Pageof 9